FOXP3 and melanoma: Tjin et al. evaluated several immune escape markers and immunosuppressive cells in stage IV melanomas; they reported very low expression of Foxp3+ in tumor-infiltrating immune cells, which suggested a minor role for Tregs in stage IV melanomas [21].